Latest News for: croi

Edit

Aligos Therapeutics Presents Positive Data at the Conference on Retroviruses and Opportunistic Infections (CROI)

Nasdaq Globe Newswire 23 Feb 2026
... Infections (CROI), being held February 22 – 25, 2026 in Denver, Colorado.
Edit

Virion Therapeutics Reports Broad and Sustained Anti-HBV Immunity Following a Single VRON-0200 Dose in the Majority of Chronically HBV-Infected Patients From its Phase 1b Study at CROI 2026

Pharmiweb 23 Feb 2026
PHILADELPHIA--(BUSINESS WIRE)--Virion Therapeutics, LLC, a clinical-stage biotechnology company developing novel T cell-based immunotherapies that utilize checkpoint modifiers, today announced at the ...
Edit

Gilead to Present New HIV Treatment and Prevention Data at CROI 2026, With a Focus ...

The Joplin Globe 17 Feb 2026
FOSTER CITY, Calif.--(BUSINESS WIRE)--Feb 17, 2026-- ... .
Edit

Gilead to Present New HIV Treatment and Prevention Data at CROI 2026, With a Focus on Expanding Options

Pharmiweb 17 Feb 2026
... Infections (CROI 2026) being held from February 22-25 in Denver, Colorado ... At CROI 2026, Gilead will present data showing how new regimens can potentially expand options and optimize HIV treatment.
  • 1

Article Search

tools
×
×
×
×